Paradigm Biopharmaceuticals Ltd News

Paradigm Biopharmaceuticals Ltd: Change in substantial holding

May 22 06:24

Paradigm Biopharmaceuticals Ltd: Application for quotation of securities - PAR

May 20 14:03

Paradigm Biopharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 30 07:54

Paradigm Biopharmaceuticals Ltd: Notification of cessation of securities - PAR

Apr 26 14:46

Paradigm Biopharmaceuticals Ltd: Type D Response Submitted and Received by the US FDA

Apr 19 06:36

Paradigm Biopharmaceuticals Ltd: Notification of cessation of securities - PAR

Apr 5 16:49

Paradigm Biopharmaceuticals Ltd: PAR to present at NWR Healthcare Conference

Mar 20 11:45

Paradigm Biopharmaceuticals Ltd: Change of Director's Interest Notice

Mar 8 10:18

Paradigm Biopharmaceuticals Ltd: Change of Director's Interest Notice

Mar 8 10:17

Paradigm Biopharmaceuticals Ltd: Final Director's Interest Notice

Mar 6 06:27

Paradigm Biopharmaceuticals Ltd: Initial Director's Interest Notice

Mar 4 08:20

Paradigm Biopharmaceuticals Ltd: Paradigm Board Changes

Mar 4 06:14

Paradigm Biopharmaceuticals Ltd: Notification regarding unquoted securities - PAR

Feb 29 07:22

Paradigm Biopharmaceuticals Ltd: PAR Employee Performance Rights Plan Issue

Feb 29 07:17

Paradigm Biopharmaceuticals Ltd: Half Yearly Report and Accounts

Feb 28 09:15

Paradigm Biopharmaceuticals Ltd: Notification regarding unquoted securities - PAR

Feb 13 10:21

Paradigm Biopharmaceuticals Ltd: Proposed issue of securities - PAR

Feb 12 05:26

Paradigm Biopharmaceuticals Ltd: PAR Appoints Business Development Consultant

Feb 9 13:45

Paradigm Biopharmaceuticals Ltd: Primary Endpoint Achieved in Phase 2 MPS VI Trial

Feb 9 06:04

Paradigm Biopharmaceuticals Ltd: Paradigm Receives $7.36m R&D Tax Incentive Refund

Feb 7 06:14